These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15109195

  • 1. Differential platelet receptor expression following hydroxyethyl starch infusion in thrombocytopaenic orthotopic liver transplantation recipients.
    Jüttner B, Kuse ER, Elsner HA, Heine J, Jaeger K, Piepenbrock S, Scheinichen D.
    Eur J Anaesthesiol; 2004 Apr; 21(4):309-13. PubMed ID: 15109195
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW.
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
    Thaler U, Deusch E, Kozek-Langenecker SA.
    Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of hydroxyethyl starches of varying molecular weights on platelet function.
    Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA.
    Anesth Analg; 2001 Jun; 92(6):1402-7. PubMed ID: 11375812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of hydroxyethyl starch on platelet aggregation in vitro.
    Blaicher AM, Reiter WJ, Blaicher W, Kettner SC, Felfernig M, Grabner CM, Zimpfer M.
    Anesth Analg; 1998 Jun; 86(6):1318-21. PubMed ID: 9620527
    [Abstract] [Full Text] [Related]

  • 11. Reduced P-selectin expression on circulating platelets after prolonged cold preservation in renal transplantation.
    Scheinichen D, zu Vilsendorf AM, Weissig A, Bornscheuer A, Becker T, Juettner B, Mahr KH, Heine J.
    Clin Transplant; 2003 Oct; 17(5):444-50. PubMed ID: 14703928
    [Abstract] [Full Text] [Related]

  • 12. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
    Zhao L, Bath PM, May J, Lösche W, Heptinstall S.
    Platelets; 2003 Oct; 14(7-8):473-80. PubMed ID: 14713516
    [Abstract] [Full Text] [Related]

  • 13. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rüdiger S, Taubitz W, Fischer J, Müller I, Meier D, Patscheke H, Schömig A.
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [Abstract] [Full Text] [Related]

  • 14. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC, Kühnel G, Kemkes-Matthes B, Pralle H, Voss R, Fareed J.
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [Abstract] [Full Text] [Related]

  • 15. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel.
    Gremmel T, Eslam RB, Koppensteiner R, Lang IM, Panzer S.
    Cardiovasc Ther; 2013 Oct; 31(5):e40-5. PubMed ID: 23311679
    [Abstract] [Full Text] [Related]

  • 16. The effects of preloading infusion with hydroxyethyl starch 200/0.5 or 130/0.4 solution on hypercoagulability and excessive platelet activation of patients with colon cancer.
    Liang H, Yang CX, Li H, Wen XJ, Zhou QL, Gu MN.
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):406-13. PubMed ID: 20614571
    [Abstract] [Full Text] [Related]

  • 17. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A, Wendel HP, Azevedo R, Ziemer G.
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [Abstract] [Full Text] [Related]

  • 18. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro.
    Scholz T, Zhao L, Temmler U, Bath P, Heptinstall S, Lösche W.
    Platelets; 2002 Nov; 13(7):401-6. PubMed ID: 12487787
    [Abstract] [Full Text] [Related]

  • 19. Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.
    Liang H, Yang C, Zhang B, Wang H, Liu H, Zhao Z, Zhang Z, Wen X, Lai X.
    Med Oncol; 2015 May; 32(5):151. PubMed ID: 25832864
    [Abstract] [Full Text] [Related]

  • 20. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH, Kottke-Marchant K, Brooks LM, Topol EJ.
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.